SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc (VCYT). (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data showing that its whole-genome sequencing (WGS)-based ...
A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following ...
We all understand the importance of data quality. Metrics—such as third-party validations, match rates, and accuracy scores—help us assess data quality on its own terms. Yet, too often, organizations ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback